- Report
- September 2022
- 202 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- August 2022
- 236 Pages
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2022
- 245 Pages
North America
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2022
- 258 Pages
Middle East, Africa
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2022
- 273 Pages
Europe
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2022
- 268 Pages
Asia Pacific
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- May 2022
- 347 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- May 2023
- 160 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- December 2021
- 120 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- July 2024
- 350 Pages
Global
From €2594EUR$2,655USD£2,166GBP
- Book
- December 2018
- 424 Pages
€2785EUR$3,053USD£2,406GBP
The Respiratory Infection market within the context of Pulmonary Medicine is a highly specialized field of medicine that focuses on the diagnosis and treatment of diseases and disorders of the respiratory system. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, and other respiratory infections. Treatment options for these conditions include medications, lifestyle changes, and in some cases, surgery.
The Respiratory Infection market is a rapidly growing field, with new treatments and technologies being developed to improve patient outcomes. Companies in this market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples of companies in this market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Show Less Read more